Login / Signup

Measuring Response to Adjunctive Therapy Among Individuals with Major Depressive Disorder.

Felicia FormaJoshua N LibermanPinyao RuiEmily WigginsCharles Ruetsch
Published in: Neuropsychiatric disease and treatment (2022)
Most individuals with moderate-to-severe MDD did not receive a follow-up questionnaire, suggesting incomplete monitoring of treatment response. Among those with a PHQ-9 following initiation of adjunctive therapy, many continued to report impactful symptoms. Future studies should explore alternate treatment approaches and methods to support the utilization of the PHQ-9 for monitoring treatment response.
Keyphrases
  • major depressive disorder
  • bipolar disorder
  • stem cells
  • high intensity
  • depressive symptoms
  • current status
  • replacement therapy
  • bone marrow
  • combination therapy
  • smoking cessation
  • sleep quality